Closing the Loophole on Hemp-Derived Cannabis Products: A Public Health Priority

Closing the Loophole on Hemp-Derived Cannabis Products: A Public Health Priority

This Viewpoint discusses a federal policy loophole that allows psychotropic cannabis products to be commercially marketed and sold across the US, even in states where recreational cannabis is not legal.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2022-11, Vol.328 (20), p.2007-2008
Hauptverfasser: Harlow, Alyssa F, Leventhal, Adam M, Barrington-Trimis, Jessica L
Format: Artikel
Sprache:eng
Schlagworte:
Cannabis
Dronabinol
Hallucinogens
Health Priorities
Hemp
Medical Marijuana - therapeutic use
Public health
Public Health Practice
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This Viewpoint discusses a federal policy loophole that allows psychotropic cannabis products to be commercially marketed and sold across the US, even in states where recreational cannabis is not legal.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2022.20620